ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD48.3

D48.3

Billable

Neoplasm of uncertain behavior of retroperitoneum

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D48.3 is a billable code used to indicate a diagnosis of neoplasm of uncertain behavior of retroperitoneum.

Key Diagnostic Point:

D48.3 refers to neoplasms located in the retroperitoneum that exhibit uncertain behavior, meaning that their potential for malignancy is not clearly defined. These neoplasms can arise from various tissues, including connective tissue, fat, and lymphatic structures. The retroperitoneum is a space in the abdominal cavity that contains vital organs such as the kidneys, adrenal glands, and major blood vessels. Neoplasms in this area may present with vague symptoms, including abdominal pain, weight loss, or a palpable mass. Diagnosis often involves imaging studies such as CT or MRI scans, and biopsy may be necessary to determine the histological nature of the tumor. Due to the uncertain behavior of these neoplasms, careful surveillance is critical, as some may progress to malignancy over time. Regular follow-up with imaging and clinical evaluation is essential to monitor for changes in size or characteristics that may indicate a shift towards malignancy. The management of these neoplasms can vary widely, from observation to surgical intervention, depending on the individual case and the specific characteristics of the tumor.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in clinical presentation and symptoms
  • Need for imaging studies and potential biopsies for diagnosis
  • Differentiation from other neoplasms with known behavior
  • Potential for progression to malignancy requiring ongoing surveillance

Audit Risk Factors

  • Inadequate documentation of clinical findings
  • Failure to document follow-up and surveillance plans
  • Misclassification of neoplasm behavior
  • Lack of imaging or biopsy results in the medical record

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans.

Common Clinical Scenarios

Management of retroperitoneal sarcomas or lymphomas.

Billing Considerations

Need for clear documentation of tumor behavior and treatment response.

Radiology

Documentation Requirements

Comprehensive imaging reports and findings.

Common Clinical Scenarios

Imaging for suspected retroperitoneal masses.

Billing Considerations

Accurate description of imaging characteristics to support diagnosis.

Coding Guidelines

Inclusion Criteria

Use D48.3 When
  • According to ICD
  • 10 guidelines, D48
  • 3 should be used when the neoplasm's behavior is uncertain and cannot be classified as benign or malignant
  • It is important to document the clinical rationale for using this code, including any imaging or biopsy results

Exclusion Criteria

Do NOT use D48.3 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

88305CPT Code

Pathology examination, surgical

Clinical Scenario

Used when a biopsy is performed to determine the nature of the retroperitoneal neoplasm.

Documentation Requirements

Pathology report detailing the findings and diagnosis.

Specialty Considerations

Oncologists should ensure that the pathology report supports the coding of uncertain behavior.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of neoplasms, including those of uncertain behavior, which aids in better tracking and management of these conditions.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of neoplasms, including those of uncertain behavior, which aids in better tracking and management of these conditions.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of neoplasms, including those of uncertain behavior, which aids in better tracking and management of these conditions.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What does 'uncertain behavior' mean in the context of neoplasms?

Uncertain behavior indicates that the neoplasm cannot be definitively classified as benign or malignant, necessitating careful monitoring and potential intervention.